Protective Role of STAT3 in NMDA and Glutamate-Induced Neuronal Death: Negative Regulatory Effect of SOCS3

PLoS ONE

Volumn 7, Issue 11, 2012, Pages

  Park, Keun W ^a   Nozell, Susan E ^a   Benveniste, Etty N ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTAMIC ACID; INTERLEUKIN 6; INTERLEUKIN 6 RECEPTOR; JANUS KINASE; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID; PROTEIN BCL XL; PROTEIN INHIBITOR; PROTEIN KINASE B; PYRIDINE; PYRIDINE 6; SERINE; STAT3 PROTEIN; SUPPRESSOR OF CYTOKINE SIGNALING 3; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CORTEX; CELL DEATH; CELL PROTECTION; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME REGULATION; HUMAN; HUMAN CELL; IN VITRO STUDY; MOUSE; NERVE CELL; NEUROBLASTOMA CELL; NEUROPROTECTION; NEUROTOXICITY; NONHUMAN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BCL-X PROTEIN; CELL DEATH; CELLS, CULTURED; ENZYME INHIBITORS; GLUTAMIC ACID; HUMANS; INTERLEUKIN-6; JANUS KINASES; MICE; MICE, INBRED C57BL; N-METHYLASPARTATE; NEURONS; NEUROPROTECTIVE AGENTS; PROTO-ONCOGENE PROTEINS C-AKT; SIGNAL TRANSDUCTION; STAT3 TRANSCRIPTION FACTOR; SUPPRESSOR OF CYTOKINE SIGNALING PROTEINS;

EID: 84870607968     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0050874     Document Type: Article

References (60)

1. Heinrich PC, Behrmann I, Haan S, Hermanns HM, Muller-Newen G, et al. (2003) Principles of interleukin (IL)-6-type cytokine signalling and its regulation. Biochem J 374: 1-20.
2. Zigmond RE, (2011) gp130 cytokines are positive signals triggering changes in gene expression and axon outgrowth in peripheral neurons following injury. Front Mol Neurosci 4: 62.
3. Deverman BE, Patterson PH, (2009) Cytokines and CNS development. Neuron 64: 61-78.
4. Sun F, He Z, (2010) Neuronal intrinsic barriers for axon regeneration in the adult CNS. Curr Opin Neurobiol 20: 510-518.
5. Guo Z, Jiang H, Xu X, Duan W, Mattson MP, (2008) Leptin-mediated cell survival signaling in hippocampal neurons mediated by JAK STAT3 and mitochondrial stabilization. J Biol Chem 283: 1754-1763.
6. Repovic P, Benveniste EN, (2002) Prostaglandin E2 is a novel inducer of oncostatin-M expression in macrophages and microglia. J Neurosci 22: 5334-5343.
7. Van Wagoner NJ, Oh JW, Repovic P, Benveniste EN, (1999) Interleukin-6 (IL-6) production by astrocytes: autocrine regulation by IL-6 and the soluble IL-6 receptor. J Neurosci 19: 5236-5244.
8. Van Wagoner NJ, Benveniste EN, (1999) Interleukin-6 expression and regulation in astrocytes. J Neuroimmunol 100: 124-139.
9. Sun Y, Marz P, Otten U, Ge J, Rose-John S, (2002) The effect of gp130 stimulation on glutamate-induced excitotoxicity in primary hippocampal neurons. Biochem Biophys Res Commun 295: 532-539.
10. Miao T, Wu D, Zhang Y, Bo X, Subang MC, et al. (2006) Suppressor of cytokine signaling-3 suppresses the ability of activated signal transducer and activator of transcription-3 to stimulate neurite growth in rat primary sensory neurons. J Neurosci 26: 9512-9519.
11. Hatta T, Moriyama K, Nakashima K, Taga T, Otani H, (2002) The role of gp130 in cerebral cortical development: in vivo functional analysis in a mouse exo utero system. J Neurosci 22: 5516-5524.
12. Bareyre FM, Garzorz N, Lang C, Misgeld T, Buning H, et al. (2011) In vivo imaging reveals a phase-specific role of STAT3 during central and peripheral nervous system axon regeneration. Proc Natl Acad Sci U S A 108: 6282-6287.
13. Baker BJ, Akhtar LN, Benveniste EN, (2009) SOCS1 and SOCS3 in the control of CNS immunity. Trends Immunol 30: 392-400.
14. Yoshimura A, Naka T, Kubo M, (2007) SOCS proteins, cytokine signalling and immune regulation. Nat Rev Immunol 7: 454-465.
15. Polizzotto MN, Bartlett PF, Turnley AM, (2000) Expression of "suppressor of cytokine signalling" (SOCS) genes in the developing and adult mouse nervous system. J Comp Neurol 423: 348-358.
16. Goldshmit Y, Greenhalgh CJ, Turnley AM, (2004) Suppressor of cytokine signalling-2 and epidermal growth factor regulate neurite outgrowth of cortical neurons. Eur J Neurosci 20: 2260-2266.
17. Nicholson SE, De Souza D, Fabri LJ, Corbin J, Willson TA, et al. (2000) Suppressor of cytokine signaling-3 preferentially binds to the SHP-2-binding site on the shared cytokine receptor subunit gp130. Proc Natl Acad Sci U S A 97: 6493-6498.
18. Schmitz J, Weissenbach M, Haan S, Heinrich PC, Schaper F, (2000) SOCS3 exerts its inhibitory function on interleukin-6 signal transduction through the SHP2 recruitment site of gp130. J Biol Chem 275: 12848-12856.
19. Babon JJ, Kershaw NJ, Murphy JM, Varghese LN, Laktyushin A, et al. (2012) Suppression of cytokine signaling by SOCS3: characterization of the mode of inhibition and the basis of its specificity. Immunity 36: 239-250.
20. Yadav A, Kalita A, Dhillon S, Banerjee K, (2005) JAK/STAT3 pathway is involved in survival of neurons in response to insulin-like growth factor and negatively regulated by suppressor of cytokine signaling-3. J Biol Chem 280: 31830-31840.
21. Smith PD, Sun F, Park KK, Cai B, Wang C, et al. (2009) SOCS3 deletion promotes optic nerve regeneration in vivo. Neuron 64: 617-623.
22. Pedranzini L, Dechow T, Berishaj M, Comenzo R, Zhou P, et al. (2006) Pyridone 6, a pan-Janus-activated kinase inhibitor, induces growth inhibition of multiple myeloma cells. Cancer Res 66: 9714-9721.
23. Baker BJ, Park KW, Qin H, Ma X, Benveniste EN, (2010) IL-27 inhibits OSM-mediated TNF-alpha and iNOS gene expression in microglia. Glia 58: 1082-1093.
24. Encinas M, Iglesias M, Liu Y, Wang H, Muhaisen A, et al. (2000) Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 75: 991-1003.
25. Qin H, Niyongere SA, Lee SJ, Baker BJ, Benveniste EN, (2008) Expression and functional significance of SOCS-1 and SOCS-3 in astrocytes. J Immunol 181: 3167-3176.
26. Ma X, Reynolds SL, Baker BJ, Li X, Benveniste EN, et al. (2010) IL-17 enhancement of the IL-6 signaling cascade in astrocytes. J Immunol 184: 4898-4906.
27. D'Arcangelo G, Tancredi V, Onofri F, D'Antuono M, Giovedi S, et al. (2000) Interleukin-6 inhibits neurotransmitter release and the spread of excitation in the rat cerebral cortex. Eur J Neurosci 12: 1241-1252.
28. Wang XQ, Peng YP, Lu JH, Cao BB, Qiu YH, (2009) Neuroprotection of interleukin-6 against NMDA attack and its signal transduction by JAK and MAPK. Neurosci Lett 450: 122-126.
29. Toulmond S, Vige X, Fage D, Benavides J, (1992) Local infusion of interleukin-6 attenuates the neurotoxic effects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 144: 49-52.
30. Moidunny S, Dias RB, Wesseling E, Sekino Y, Boddeke HW, et al. (2010) Interleukin-6-type cytokines in neuroprotection and neuromodulation: oncostatin M, but not leukemia inhibitory factor, requires neuronal adenosine A1 receptor function. J Neurochem 114: 1667-1677.
31. Weiss TW, Samson AL, Niego B, Daniel PB, Medcalf RL, (2006) Oncostatin M is a neuroprotective cytokine that inhibits excitotoxic injury in vitro and in vivo. FASEB J 20: 2369-2371.
32. Scheller J, Ohnesorge N, Rose-John S, (2006) Interleukin-6 trans-signalling in chronic inflammation and cancer. Scand J Immunol 63: 321-329.
33. Wormald S, Hilton DJ, (2004) Inhibitors of cytokine signal transduction. J Biol Chem 279: 821-824.
34. Billen LP, Kokoski CL, Lovell JF, Leber B, Andrews DW, (2008) Bcl-XL inhibits membrane permeabilization by competing with Bax. PLoS Biol 6: e147.
35. Chen YB, Aon MA, Hsu YT, Soane L, Teng X, et al. (2011) Bcl-xL regulates mitochondrial energetics by stabilizing the inner membrane potential. J Cell Biol 195: 263-276.
36. Kuo ML, Chuang SE, Lin MT, Yang SY, (2001) The involvement of PI3-K/Akt-dependent up-regulation of Mcl-1 in the prevention of apoptosis of Hep3B cells by interleukin-6. Oncogene 20: 677-685.
37. Zhao L, Hart S, Cheng J, Melenhorst JJ, Bierie B, et al. (2004) Mammary gland remodeling depends on gp130 signaling through Stat3 and MAPK. J Biol Chem 279: 44093-44100.
38. Jones SA, Scheller J, Rose-John S, (2011) Therapeutic strategies for the clinical blockade of IL-6/gp130 signaling. J Clin Invest 121: 3375-3383.
39. Dziennis S, Alkayed NJ, (2008) Role of signal transducer and activator of transcription 3 in neuronal survival and regeneration. Rev Neurosci 19: 341-361.
40. Dziennis S, Jia T, Ronnekleiv OK, Hurn PD, Alkayed NJ, (2007) Role of signal transducer and activator of transcription-3 in estradiol-mediated neuroprotection. J Neurosci 27: 7268-7274.
41. Lang R, Pauleau AL, Parganas E, Takahashi Y, Mages J, et al. (2003) SOCS3 regulates the plasticity of gp130 signaling. Nat Immunol 4: 546-550.
42. Croker BA, Krebs DL, Zhang JG, Wormald S, Willson TA, et al. (2003) SOCS3 negatively regulates IL-6 signaling in vivo. Nat Immunol 4: 540-545.
43. Roberts AW, Robb L, Rakar S, Hartley L, Cluse L, et al. (2001) Placental defects and embryonic lethality in mice lacking suppressor of cytokine signaling 3. Proc Natl Acad Sci U S A 98: 9324-9329.
44. Ernst MB, Wunderlich CM, Hess S, Paehler M, Mesaros A, et al. (2009) Enhanced Stat3 activation in POMC neurons provokes negative feedback inhibition of leptin and insulin signaling in obesity. J Neurosci 29: 11582-11593.
45. Miao T, Wu D, Zhang Y, Bo X, Xiao F, et al. (2008) SOCS3 suppresses AP-1 transcriptional activity in neuroblastoma cells through inhibition of c-Jun N-terminal kinase. Mol Cell Neurosci 37: 367-375.
46. Mori H, Hanada R, Hanada T, Aki D, Mashima R, et al. (2004) Socs3 deficiency in the brain elevates leptin sensitivity and confers resistance to diet-induced obesity. Nat Med 10: 739-743.
47. Hellstrom M, Muhling J, Ehlert EM, Verhaagen J, Pollett MA, et al. (2011) Negative impact of rAAV2 mediated expression of SOCS3 on the regeneration of adult retinal ganglion cell axons. Mol Cell Neurosci 46: 507-515.
48. Sun F, Park KK, Belin S, Wang D, Lu T, et al. (2011) Sustained axon regeneration induced by co-deletion of PTEN and SOCS3. Nature 480: 372-375.
49. Metlakunta AS, Sahu M, Yasukawa H, Dhillon SS, Belsham DD, et al. (2011) Neuronal suppressor of cytokine signaling-3 deficiency enhances hypothalamic leptin-dependent phosphatidylinositol 3-kinase signaling. Am J Physiol Regul Integr Comp Physiol 300: R1185-1193.
50. Yamashita T, Sawamoto K, Suzuki S, Suzuki N, Adachi K, et al. (2005) Blockade of interleukin-6 signaling aggravates ischemic cerebral damage in mice: possible involvement of Stat3 activation in the protection of neurons. J Neurochem 94: 459-468.
51. Jung JE, Kim GS, Chen H, Maier CM, Narasimhan P, et al. (2010) Reperfusion and neurovascular dysfunction in stroke: from basic mechanisms to potential strategies for neuroprotection. Mol Neurobiol 41: 172-179.
52. Qin H, Roberts KL, Niyongere SA, Cong Y, Elson CO, et al. (2007) Molecular mechanism of lipopolysaccharide-induced SOCS-3 gene expression in macrophages and microglia. J Immunol 179: 5966-5976.
53. Qin H, Wilson CA, Roberts KL, Baker BJ, Zhao X, et al. (2006) IL-10 inhibits lipopolysaccharide-induced CD40 gene expression through induction of suppressor of cytokine signaling-3. J Immunol 177: 7761-7771.
54. Dominguez E, Mauborgne A, Mallet J, Desclaux M, Pohl M, (2010) SOCS3-mediated blockade of JAK/STAT3 signaling pathway reveals its major contribution to spinal cord neuroinflammation and mechanical allodynia after peripheral nerve injury. J Neurosci 30: 5754-5766.
55. Qin H, Yeh WI, De Sarno P, Holdbrooks AT, Liu Y, et al. (2012) Signal transducer and activator of transcription-3/suppressor of cytokine signaling-3 (STAT3/SOCS3) axis in myeloid cells regulates neuroinflammation. Proc Natl Acad Sci U S A 109: 5004-5009.
56. Li Y, Chu N, Rostami A, Zhang GX, (2006) Dendritic cells transduced with SOCS-3 exhibit a tolerogenic/DC2 phenotype that directs type 2 Th cell differentiation in vitro and in vivo. J Immunol 177: 1679-1688.
57. Mayer M, Bhakoo K, Noble M, (1994) Ciliary neurotrophic factor and leukemia inhibitory factor promote the generation, maturation and survival of oligodendrocytes in vitro. Development 120: 143-153.
58. Linker RA, Maurer M, Gaupp S, Martini R, Holtmann B, et al. (2002) CNTF is a major protective factor in demyelinating CNS disease: a neurotrophic cytokine as modulator in neuroinflammation. Nat Med 8: 620-624.
59. Butzkueven H, Zhang JG, Soilu-Hanninen M, Hochrein H, Chionh F, et al. (2002) LIF receptor signaling limits immune-mediated demyelination by enhancing oligodendrocyte survival. Nat Med 8: 613-619.
60. Emery B, Cate HS, Marriott M, Merson T, Binder MD, et al. (2006) Suppressor of cytokine signaling 3 limits protection of leukemia inhibitory factor receptor signaling against central demyelination. Proc Natl Acad Sci U S A 103: 7859-7864.